215
Participants
Start Date
June 30, 2015
Primary Completion Date
July 31, 2018
Study Completion Date
July 31, 2018
CHRU de Brest, Brest
Université catholique de Louvain - Cliniques Universitaires Saint-Luc (UCL), Brussels
UZ Leuven - KU Leuven, Department of Rheumatology (KU LEUVEN), Leuven
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ), Berlin
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico (IRCCS), Milan
Hospital Clinic I Provicia- Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
Hospital Universitario Reina Sofía Andaluz de Salud, Córdoba
Hospital Universitario San Cecilio Servicio Andaluz de Salud, Granada
Hospital Virgen de las Nieves Granada, Granada
Hospitaux Universitaires de Géneve (UNIGE), Geneva
Collaborators (4)
UCB Biopharma S.P.R.L.
INDUSTRY
Atrys Health
INDUSTRY
National Research Council, Spain
OTHER_GOV
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
OTHER
Servicio Cántabro de Salud
OTHER
August Pi Sunyer Biomedical Research Institute
OTHER
Karolinska Institutet
OTHER
KU Leuven
OTHER
Klinikum der Universität Köln
OTHER
Hannover Medical School
OTHER
Medical University of Vienna
OTHER
Quartz Bio S.A.
OTHER
Andaluz Health Service
OTHER_GOV
The Cyprus Foundation for Muscular Dystrophy Research
OTHER
Universidad de Granada
OTHER
University of Milan
OTHER
Université Catholique de Louvain
OTHER
University Hospital, Brest
OTHER
University of Geneva, Switzerland
OTHER
Szeged University
OTHER
Bayer
INDUSTRY
Institut de Recherches Internationales Servier
OTHER
Sanofi
INDUSTRY
Eli Lilly and Company
INDUSTRY
Charite University, Berlin, Germany
OTHER
Centro Hospitalar do Porto
OTHER
Institut d'Investigació Biomèdica de Bellvitge
OTHER
Innovative Medicines Initiative
OTHER
Fundación Pública Andaluza Progreso y Salud
OTHER